Hemodialysis patients: 1 trials - Nishimura
| nicorandil vs control | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| unstable angina | no data | | PCI | no data | | Coronary revascularization | no data | | Hospitalization for angina | no data | | Cardiovascular death or hospital admission for CHF | no data | | CV death, MI hospitalization for HF | no data | | cardiovascular events | no data | | Cardiovascular death | no data | | myocardial infarction (fatal and non fatal) | no data | | stroke (fatal and non fatal) | no data | | Coronary event | no data | | cardiac death | no data | | CABG | no data | | Non fatal MI | no data | | hospitalisation for heart failure | no data | | All cause death | no data |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
Hemodialysis patients: 1 trials - Nishimura
| nicorandil vs control | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| unstable angina | no data | | PCI | no data | | Coronary revascularization | no data | | Hospitalization for angina | no data | | Cardiovascular death or hospital admission for CHF | no data | | CV death, MI hospitalization for HF | no data | | cardiovascular events | no data | | Cardiovascular death | no data | | myocardial infarction (fatal and non fatal) | no data | | stroke (fatal and non fatal) | no data | | Coronary event | no data | | cardiac death | no data | | CABG | no data | | Non fatal MI | no data | | hospitalisation for heart failure | no data | | All cause death | no data |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
